SIMPLEX TRADING, LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 93 filers reported holding LYELL IMMUNOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2023$0553
+2972.2%
0.00%
Q1 2023$018
-76.9%
0.00%
Q3 2022$0
-100.0%
78
-97.7%
0.00%
Q2 2022$22,000
+15.8%
3,378
-13.7%
0.00%
Q1 2022$19,000
+58.3%
3,913
+138.9%
0.00%
Q4 2021$12,0001,6380.00%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$156,056,00045.49%
Foresite Capital Management IV, LLC 13,282,181$102,804,00021.15%
Apoletto Ltd 15,093,969$116,827,00014.55%
SB Management Ltd 3,500,000$27,090,0002.68%
HSG Holding Ltd 3,045,997$23,576,0002.11%
MIC Capital Management UK LLP 1,320,000$10,217,0001.95%
Alphabet Inc. 5,865,125$45,396,0001.10%
Board of Trustees of The Leland Stanford Junior University 1,647,882$12,754,0000.80%
Adero Partners, LLC 491,372$3,803,0000.62%
Ergoteles LLC 1,008,428$7,805,0000.30%
View complete list of LYELL IMMUNOPHARMA INC shareholders